These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36396496)

  • 1. Digoxin as an emerging therapy in noncardiac diseases.
    Dashti F; Jamshed F; Ouyang X; Mehal WZ; Banini BA
    Trends Pharmacol Sci; 2023 Apr; 44(4):199-203. PubMed ID: 36396496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
    Cherniavsky Lev M; Karlish SJ; Garty H
    Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why Whip the Starving Horse When There Are Oats for the Starving Myocardium?
    Fürstenwerth H
    Am J Ther; 2016; 23(5):e1182-7. PubMed ID: 25259953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
    Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
    Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
    Gupta RS; Chopra A
    J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
    Chopra A; Gupta RS
    J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1.
    Hauck C; Potter T; Bartz M; Wittwer T; Wahlers T; Mehlhorn U; Scheiner-Bobis G; McDonough AA; Bloch W; Schwinger RH; Müller-Ehmsen J
    Eur J Pharmacol; 2009 Nov; 622(1-3):7-14. PubMed ID: 19751721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Na,K-ATPase and digoxin therapy in human heart failure.
    Kjeldsen K; Bundgaard H
    Ann N Y Acad Sci; 2003 Apr; 986():702-7. PubMed ID: 12763921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No upregulation of digitalis glycoside receptor (Na,K-ATPase) concentration in human heart left ventricle samples obtained at necropsy after long term digitalisation.
    Schmidt TA; Holm-Nielsen P; Kjeldsen K
    Cardiovasc Res; 1991 Aug; 25(8):684-91. PubMed ID: 1655269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The highly conserved cardiac glycoside binding site of Na,K-ATPase plays a role in blood pressure regulation.
    Dostanic-Larson I; Van Huysse JW; Lorenz JN; Lingrel JB
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):15845-50. PubMed ID: 16243970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an amino acid substitution in human alpha 1 Na,K-ATPase which confers differentially reduced affinity for two related cardiac glycosides.
    Askew GR; Lingrel JB
    J Biol Chem; 1994 Sep; 269(39):24120-6. PubMed ID: 7929066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Na
    Shandell MA; Capatina AL; Lawrence SM; Brackenbury WJ; Lagos D
    J Biol Chem; 2022 Mar; 298(3):101707. PubMed ID: 35150740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
    Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
    J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer cell-specific functional relation between Na
    Fujii T; Shimizu T; Takeshima H; Sakai H
    Nihon Yakurigaku Zasshi; 2019; 154(3):103-107. PubMed ID: 31527358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Insights into the Interactions of Digoxin and Na
    Ren Y; Wu S; Burdette JE; Cheng X; Kinghorn AD
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34208576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repurposing Cardiac Glycosides: Drugs for Heart Failure Surmounting Viruses.
    Škubník J; Bejček J; Pavlíčková VS; Rimpelová S
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-resistance and biochemical characteristics of second-step mutants of HeLa cells resistant to cardiac glycosides.
    Chopra A; Dudani AK; Gupta RS
    Biochem Cell Biol; 1990 May; 68(5):852-7. PubMed ID: 2169261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoschisin and Cardiac Glycoside Crosstalk at the Retinal Na/K-ATPase.
    Schmid V; Plössl K; Schmid C; Bernklau S; Weber BHF; Friedrich U
    Invest Ophthalmol Vis Sci; 2020 May; 61(5):1. PubMed ID: 32392309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
    Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
    Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.